FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults

FDA halts public release of Complete Response Letters, following citizen petition

FDA will temporarily stop publicly releasing rejection letters as it evaluates potential response to a citizen petition issued by an unnamed pharmaceutical company challenging the legality of the practice.

July 10, 2026

Vol.52 No.27

By Claire Marie Porter

Cancer Policy

FDA proposes rule to hold foreign tobacco companies to U.S. standards

FDA has issued a proposed rule to require both foreign and domestic tobacco manufacturers to register their facilities and list their products with the agency. This closes a regulatory gap, holding overseas e-cigarette and tobacco makers to the same standards as U.S. companies.

July 10, 2026

Vol.52 No.27

By Claire Marie Porter

Cancer Policy

CDC updates ACIP charter

The Centers for Disease Control and Prevention has published an updated version of the charter for the Advisory Committee on Immunization Practices.

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

FDA is allowing ZYN nicotine pouches, a tobaccoless product that has soared in popularity since in recent years, to make the claim that its products are safer than cigarettes.

FDA approved 17 new cancer treatments in 2025, OCE annual report states

FDA’s Oncology Center of Excellence released its 2025 Annual Report.

July 02, 2026

Vol.52 No.26

Drugs & Targets

FDA approves Trodelvy for first-line treatment of mTNBC

FDA approved Trodelvy (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate, for the first-line treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer.

July 02, 2026

Vol.52 No.26

FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults

YOU MAY BE INTERESTED IN

FDA halts public release of Complete Response Letters, following citizen petition

FDA proposes rule to hold foreign tobacco companies to U.S. standards

CDC updates ACIP charter

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

FDA approved 17 new cancer treatments in 2025, OCE annual report states

FDA approves Trodelvy for first-line treatment of mTNBC

Renew today!

Subscriber content

Never miss an issue!

Login